Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Carcinoma, Renal Cell × Nivolumab × Clear all

Phase

Phase 2 41 Phase 1 33 Phase 1/2 29 Phase 3 12 Phase 4 4 Phase NA 1 Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Melanoma 3 Skin Neoplasms 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Carcinoma 1 Neoplasms 1 Malignant Ascites 1 Lung Neoplasms 1 Glioma 1 Drug-Related Side Effects and Adverse Reactions 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

Radiosurgery 9 Sunitinib 8 pazopanib 4 Standard of Care 4 Practice Guidelines as Topic 4 Magnetic Resonance Spectroscopy 4 Exercise 3 Everolimus 3 Blood Specimen Collection 3 gallium 68 PSMA-11 2 fludarabine phosphate 2 Sutures 2 Surveys and Questionnaires 2 Sorafenib 2 Radiofrequency Ablation 2 Peripheral Blood Stem Cell Transplantation 2 Optical Imaging 2 Occupational Therapy 2 Nephrectomy 2 Fluorodeoxyglucose F18 2 Early Intervention, Educational 2 Cyclophosphamide 2 Cryosurgery 2 Busulfan 2 Bevacizumab 2 tivozanib 1 temsirolimus 1 propacetamol 1 etoposide phosphate 1 diacetamate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07233668 2025-12-03

IVE in mRCC

Seoul National University Hospital

Phase NA Not yet recruiting

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡